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Solid dosage forms are still the most preferred types of medicines in the pharmaceutical 
market. Due to the emerging trend on personalized medicine, the pharmaceutical industry 
faces a new challenge on providing matrix systems with tailorable properties. To fulfil this 
request, a novel approach of pharmaceutical design may be applied with a more detailed 
investigation of physico-chemical property-based interactions between the drug and the 
applied excipients. The main aim of this research work is the better understanding of these 
interactions and fulfilling the requirements of the ‘Functionality related properties of 
materials’ concept of Quality by Design. 
A line of chemically similar APIs and matrix forming agents were mixed and directly 
compressed with an instrumented IMA Kilian SP300 tablet press. The interactions formed 
within the tablets were studied by FT-IR and NIR spectroscopy, and a custom-made device was 
used to perform dissolution tests to obtain information about the effects of interactions on 
the drug liberation kinetics. 
The spectral information revealed that hydrogen bonds are formed between the drug and 
excipients even in solid state, while investigations during dissolution tests proved that the 
strength of interactions increased due to the formation of polyelectrolyte complexes, which 
affects not just the speed of drug liberation but also the quantity of the liberated drug. 
According to the findings it can be concluded that in addition to the physico-chemical 
properties of the drug delivery system, drug liberation is considerably influenced by the 
chemical interactions formed between APIs and excipients.  
 
Supervisors: Tamás Sovány, Ildikó Csóka 
  
DOI: 10.14232/syrptbrs.2020.op28 
 
